Therapeutic progress with topical liposome drugs for skin disease

被引:77
作者
Schmid, MH [1 ]
Korting, HC [1 ]
机构
[1] UNIV MUNICH, DERMATOL KLIN & POLIKLIN, D-80337 MUNICH, GERMANY
关键词
drug carrier system; liposome; skin disease; topical application;
D O I
10.1016/0169-409X(95)00019-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It was more than three decades ago that liposomes were first discussed as drug delivery systems. Yet in the dermatological field liposomes were used initially only because of their moisturizing and restoring action. Later their capability of enclosing many different biological materials and of delivering them to the epidermal cells or even deeper cell layers was investigated. This offered new perspectives: Whereas systemically applied liposome drugs often proved disappointing topical drug delivery seemed to have some advantages: Pharmaceutical substances such as glucocorticosteroids, retinoids and local anesthetics incorporated into liposomes showed greater effectiveness making shorter application periods possible as well as a decrease of side effects. This leads to the conclusion that liposomes may be useful vehicles for topical drug delivery in the context of varying skin diseases.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 47 条
[1]   LONG-CIRCULATING (STERICALLY STABILIZED) LIPOSOMES FOR TARGETED DRUG-DELIVERY [J].
ALLEN, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :215-220
[2]   IN-VITRO TESTS TO PREDICT IN-VIVO PERFORMANCE OF LIPOSOMAL DOSAGE FORMS [J].
AMSELEM, S ;
COHEN, R ;
BARENHOLZ, Y .
CHEMISTRY AND PHYSICS OF LIPIDS, 1993, 64 (1-3) :219-237
[3]   THE INVITRO RELEASE OF STEROIDS FROM LIPOSOMES [J].
ARROWSMITH, M ;
HADGRAFT, J ;
KELLAWAY, IW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 14 (2-3) :191-208
[4]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[5]  
BARRY B W, 1987, P121
[6]  
Braun-Falco O., 1992, LIPOSOME DERMATICS, P91, DOI DOI 10.1007/978-3-642-48391-2_10
[7]   TOPICAL DELIVERY OF LIPOSOMALLY ENCAPSULATED GAMMA-INTERFERON [J].
DUPLESSIS, J ;
EGBARIA, K ;
RAMACHANDRAN, C ;
WEINER, N .
ANTIVIRAL RESEARCH, 1992, 18 (3-4) :259-265
[8]  
EGBARIA K, 1990, Advanced Drug Delivery Reviews, V5, P287, DOI 10.1016/0169-409X(90)90021-J
[9]   DERMAL EFFECTS OF COMPOSITIONS BASED ON THE EUTECTIC MIXTURE OF LIGNOCAINE AND PRILOCAINE (EMLA) - STUDIES IN VOLUNTEERS [J].
EVERS, H ;
VONDARDEL, O ;
JUHLIN, L ;
OHLSEN, L ;
VINNARS, E .
BRITISH JOURNAL OF ANAESTHESIA, 1985, 57 (10) :997-1005
[10]   TOPICAL LIPOSOMAL LOCAL-ANESTHETICS - DESIGN, OPTIMIZATION AND EVALUATION OF FORMULATIONS [J].
FOLDVARI, M ;
GESZTES, A ;
MEZEI, M ;
CARDINAL, L ;
KOWALCZYK, I ;
BEHL, M .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (19) :2499-2517